May 26, 2010
by Paul Paul D Maher, MD MPH
- There is zero direct clinical evidence that Gardasil decreases cervical cancer rates. The FDA approval was made based off an effect on immunity to human papilloma virus.
- Western medicine does not have a great track record in treating cancer, let alone trying to prevent it decades down the line.
- There has never been a preventive cancer vaccine that has been seen to work in the past.
- HPV, against which the vaccine is directed, may simply be a “disease marker” in the same way that nicotine stained yellow fingers are a disease marker for lung cancer, while washing ones hands would have zero affect on lung cancer rates.
- If one accepts that HPV is necessary for cancer development, it would seem highly reckless without massive safety data to suppose a-priori that inoculation with 4 strains of HPV viral epitope would be inherently safe and might not itself promote cervical cancer while any evidence for this would take decades to be seen.
- Vaccine based immunity declines over time and there is no evidence that Gardasil induces a necessary long term immunity to HPV, while any decline in protection is magnified because the vaccine only protects against a portion of strains of HPV found to be associated with cervical cancer.
- The regulatory process had been compromised by direct financial ties between the vaccine manufacturer and regulators, not to mention the political pressures brought to bear by a well-funded lobbying effort.
- Even if the vaccine showed some degree of efficacy, a resulting decline in annual surveillance for early cervical cancer might still lead to a net increase in cervical cancer deaths.